Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Physiology
Xiaoxiang ZhouHongfeng Lin

Abstract

Background and Objective: Galectin-9 (Gal-9) is one of the galectin family members which are known as proteins with β-galactoside-binding affinity. Accumulative evidence suggest that Gal-9 plays multifaceted roles in tumor biology. However, the prognostic significance of Gal-9 in solid cancer patients remains controversial. The objective of the study was to clarify the prognostic significance of Gal-9 in solid tumors via meta-analysis. Methods: We searched PubMed, Embase and the Cochrane library for studies that report the correlation between Gal-9 expression and prognosis or clinicopathological parameters in solid cancer patients from inception to October 2017, with no language restriction. We calculated pooled hazard ratio (HR) and 95% confidence interval (CI) to investigate the prognostic significance of Gal-9 expression in solid tumors. We also calculated Odds ratio (OR) to explore the association between Gal-9 expression and clinicopathological features. Results: We included Fourteen studies with 2326 patients in our meta-analysis. The synthetic results revealed that high Gal-9 expression indicated improved overall survival (OS; HR = 0.70, 95% CI = 0.51-0.71, P = 0.006) but had no correlation with disease-free survival (DF...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 12, 2002·Glycobiology·Sophie ChabotMitsuomi Hirashima
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Toshiro KageshitaMitsuomi Hirashima
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·C Allison GrayThomas E Spencer
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akemi IrieMitsuomi Hirashima
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Jun 30, 2006·Contemporary Clinical Trials·Rebecca DerSimonian, Raghu Kacker
Sep 9, 2006·The Breast Journal·Akira YamauchiMitsuomi Hirashima
Nov 1, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Atsuya NobumotoMitsuomi Hirashima
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keiko NagaharaMitsuomi Hirashima
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Dec 20, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Takeshi KadowakiMitsuomi Hirashima
Apr 17, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hang LiWeiping Zou
May 11, 2012·The Journal of Investigative Dermatology·Valerie R WiersmaEdwin Bremer
Aug 3, 2012·Nature Cell Biology·Peter FriedlJeffrey E Segall
Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Zhao-Yang ZhangXue-Dong Wang
Feb 27, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hangcheng FuJiejie Xu
Apr 1, 2015·International Journal of Oncology·Koji FujitaTsutomu Masaki
Jan 23, 2016·International Journal of Oncology·Tomoko TadokoroTsutomu Masaki
Jan 14, 2017·Molecular Oncology·Pahini PandyaVictoria Sanz-Moreno
May 12, 2017·The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology·Sang Il ChoiSoo Jeong Cho
Jun 29, 2017·International Journal of Oncology·Tomoko TadokoroTsutomu Masaki
Sep 8, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shravan MadireddiMichael Croft
Feb 2, 2018·Oncology Letters·Ryoichi OkuraTsutomu Masaki
Feb 2, 2018·International Journal of Molecular Sciences·Feng-Cheng ChouHuey-Kang Sytwu

❮ Previous
Next ❯

Citations

May 28, 2019·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Julie AntomarchiHeidy Schmid-Antomarchi
Oct 15, 2019·Journal of Cellular Physiology·Feng YuanXuejun Yang
Nov 16, 2019·Investigative Ophthalmology & Visual Science·Annemijn P A WierengaMartine J Jager
Apr 1, 2020·International Journal of Molecular Sciences·Joanna K BujakKinga Majchrzak-Kuligowska
Jan 18, 2019·PloS One·Maria Sofia BasileMichele Reibaldi
Nov 12, 2019·The Journal of Clinical Investigation·Asmi Chakraborty, Charles J Dimitroff
Mar 7, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jacob CurleyAnne M Mills
Feb 18, 2020·Frontiers in Immunology·Gustavo Rodrigues RossiFernando Souza-Fonseca-Guimaraes
Nov 22, 2019·Frontiers in Oncology·Maria Sofia BasileMichele Reibaldi
Oct 22, 2020·Journal for Immunotherapy of Cancer·Peixin ChenCaicun Zhou
Jul 14, 2020·Seminars in Cancer Biology·Ombretta MelaiuFederica Gemignani
Jan 26, 2021·Cellular Immunology·Preeti Moar, Ravi Tandon
Nov 7, 2020·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Vasilios PergialiotisKonstantinos Kontzoglou

❮ Previous
Next ❯

Software Mentioned

Engauge Digitizer

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.